Prevention of Renal and Vascular End-stage Disease Intervention Trial - PREVEND IT


The goal of the trial was to evaluate if urinary albumin excretion levels are associated with cardiovascular events in patients with microalbuminuria excretion and without hypertension and hypercholesterolemia, and to evalute if treatment with pravastatin or the ACE-inhibitor fosinopril is associated with a reduction in microalbuminuria excretion and cardiovascular events.